Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.

Source:http://linkedlifedata.com/resource/pubmed/id/17121882

Clin. Cancer Res. 2006 Nov 15 12 22 6637-42

Download in:

View as

General Info

PMID
17121882